From Surf Wiki (app.surf) — the open knowledge base
List of benzodiazepines
none
none
The tables below contain a sample list of benzodiazepines and benzodiazepine analogs that are commonly prescribed, with their basic pharmacological characteristics, such as half-life and equivalent doses to other benzodiazepines, also listed, along with their trade names and primary uses. The elimination half-life is how long it takes for half of the drug to be eliminated by the body. "Time to peak" refers to when maximum levels of the drug in the blood occur after a given dose. Benzodiazepines generally share the same pharmacological properties, such as anxiolytic, sedative, hypnotic, skeletal muscle relaxant, amnesic, and anticonvulsant effects. Variation in potency of certain effects may exist amongst individual benzodiazepines. Some benzodiazepines produce active metabolites. Active metabolites are produced when a person's body metabolizes the drug into compounds that share a similar pharmacological profile to the parent compound and thus are relevant when calculating how long the pharmacological effects of a drug will last. Long-acting benzodiazepines with long-acting active metabolites, such as diazepam and chlordiazepoxide, are often prescribed for benzodiazepine or alcohol withdrawal as well as for anxiety if constant dose levels are required throughout the day. Shorter-acting benzodiazepines are often preferred for insomnia due to their lesser hangover effect.
It is fairly important to note that elimination half-life of diazepam and chlordiazepoxide, as well as other long half-life benzodiazepines, is twice as long in the elderly compared to younger individuals. Due to increased sensitivity and potentially dangerous adverse events among elderly patients, it is recommended to avoid prescribing them as specified by the 2015 American Geriatrics Society Beers Criteria. Individuals with an impaired liver also metabolize benzodiazepines more slowly. Thus, the approximate equivalent of doses below may need to be adjusted accordingly in individuals on short acting benzodiazepines who metabolize long-acting benzodiazepines more slowly and vice versa. The changes are most notable with long acting benzodiazepines as these are prone to significant accumulation in such individuals and can lead to withdrawal symptoms. For example, the equivalent dose of diazepam in an elderly individual on lorazepam may be half of what would be expected in a younger individual. Equivalent doses of benzodiazepines differ as much as 20 fold.
Pharmacokinetic properties of various benzodiazepines
Equivalency data in the table below is taken from the Ashton "Benzodiazepine Equivalence Table".
| Drug Name | Common Trade Names | data-sort-type="number" | Year Approved | Typical Oral Dosage Formulations | Approx. Equivalent Oral Dose to 10 mg Diazepam (mg) | data-sort-type="number" | Peak Onset of Action | Elimination Half-life of Active Metabolite (hours) | Primary Therapeutic Use | Drug Name | Common Trade Names | Year Approved | Typical Dosages of Oral Tablets | Approx. Equivalent Oral Dose to 10 mg Diazepam (mg) | Peak onset of action (hours) | Elimination Half-life of Active Metabolite (hours) | Primary Therapeutic Use | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adinazolam | Deracyn | 1–2 | 3 | anxiolytic, antidepressant | |||||||||||||||||
| Alprazolam | Alprox, Farmapram, Frontin, Helex, Kalma, Ksalol, Misar, Neurol, Onax, Restyl, Solanax, Tafil, Trankimazin, Xanax, Xanor | 0.25, 0.5, 1, 2 | 0.5 | 1–3 | vauthors = Moylan S, Giorlando F, Nordfjærn T, Berk M | title = The role of alprazolam for the treatment of panic disorder in Australia | journal = The Australian and New Zealand Journal of Psychiatry | volume = 46 | issue = 3 | pages = 212–224 | date = March 2012 | pmid = 22391278 | doi = 10.1177/0004867411432074 | s2cid = 11006795 }} | anxiolytic, antidepressant | ||||||
| Bentazepam | Thiadipona | 25 | 1–3 | 2–4 | anxiolytic | ||||||||||||||||
| Bretazenil | 2.5 | anxiolytic, anticonvulsant | |||||||||||||||||||
| Bromazepam | Bromam, Lectopam, Lexatin, Lexaurin, Lexilium, Lexotan, Lexotanil | 1.5, 3, 6 | 6 | 1–5 | 20–40 | anxiolytic, | |||||||||||||||
| Bromazolam | 2 , 4 | 2 | anxiolytic | ||||||||||||||||||
| Brotizolam | Dormex, Lendormin, Noctilan, Sintonal, | 0.25 | 0.5 | 0.5–2 | 4–5 | hypnotic | |||||||||||||||
| Camazepam | Albego, Limpidon | 40 | 1–3 | 6–11 | anxiolytic | ||||||||||||||||
| Chlordiazepoxide | Elenium, Librium, Risolid | 5, 10, 25 | 25 | 1.5–6 | 36–200 | anxiolytic | |||||||||||||||
| Cinazepam | Levana | 0.5, 1, 2 | 2–4 | 60 | hypnotic, anxiolytic | ||||||||||||||||
| Cinolazepam | Gerodorm | 40 | 0.5–2 | 9 | hypnotic | ||||||||||||||||
| Clobazam | Frisium, Onfi, Urbanol | 5, 10, 20 | 20 | 1–5 | 8–60 | anxiolytic, anticonvulsant | |||||||||||||||
| Clonazepam | Iktorivil, Klonopin, Paxam, Rivatril, Rivotril | 0.5, 1, 2 | 0.5-1 | 1–5 | 19.5–50 | anticonvulsant, anxiolytic | |||||||||||||||
| Clonazolam | 0.25, 0.5 | 0.2 | 0.5-1 | 3-4 | hypnotic, anticonvulsant | ||||||||||||||||
| Clorazepate | Tranxene, Tranxilium | 3.75, 5, 7.5 | 15 | Variable | 32–152 | anxiolytic, anticonvulsant | |||||||||||||||
| Clotiazepam{{Efn | group=}} | Clozan, Rize, Veratran | 5, 10 | 10 | 1–3 | 4 | anxiolytic | ||||||||||||||
| Cloxazolam | Cloxam, Olcadil, Sepazon | 1, 2, 4 | 1.5 | 2–5 | 55–77 | anxiolytic, anticonvulsant | |||||||||||||||
| Delorazepam | Dadumir | 0.5, 1, 2 | 1-1.5 | 1–2 | 79 | anxiolytic, amnesic | |||||||||||||||
| Deschloroetizolam | 1, 2 | 4 | anxiolytic | ||||||||||||||||||
| Diazepam | Antenex, Apaurin, Apozepam, Apzepam, Diazepan, Hexalid, Normabel, Pax, Stedon, Stesolid, Tranquirit, Valaxona, Valium, Vival | 2, 5, 10 | 10 | 1–1.5 | 32–205 | anxiolytic, anticonvulsant, muscle relaxant, amnesic | |||||||||||||||
| Diclazepam | 1, 2 | 2 | 1.5–3 | 42 | anxiolytic, muscle relaxant | ||||||||||||||||
| Estazolam | ProSom, Nuctalon | 1, 2 | 2 | 3–5 | 10–24 | hypnotic, anxiolytic | |||||||||||||||
| Ethylbromazolam | 4 (approx. half as potent as bromazolam) | anxiolytic | |||||||||||||||||||
| Ethyl carfluzepate | 2 | 1–5 | 11–24 | hypnotic | |||||||||||||||||
| Etizolam | Depas, Etilaam, Etizest, Pasaden | 1 | 2 | 1–3 | 5-7 | anxiolytic, muscle relaxant, anticonvulsant | |||||||||||||||
| Ethyl loflazepate | Meilax, Ronlax, Victan | url=http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html | title=Benzodiazepine Names | access-date=2009-05-31 | publisher=non-benzodiazepines.org.uk | archive-url=https://web.archive.org/web/20081208054743/http://www.non-benzodiazepines.org.uk/benzodiazepine-names.html | archive-date=2008-12-08}} | 2.5–3 | 73–119 | anxiolytic | |||||||||||
| Flualprazolam | 0.5, 1 | 0.25 | 1-2 | 12-22 | anxiolytic, hypnotic | ||||||||||||||||
| Flubromazepam | Templex | 4, 8, 12 | 4 | 1.5–8 | 100–220 | anxiolytic, hypnotic, amnesic, muscle relaxant, anticonvulsant | |||||||||||||||
| Flubromazolam | Remnon | 0.25, 0.5 | 0.075 | 0.5-5 | 10-20 | hypnotic | |||||||||||||||
| Fluclotizolam | 0.25-0.5 | anxiolytic | |||||||||||||||||||
| Flunitrazepam | Flunipam, Fluscand, Hipnosedon, Hypnodorm, Rohydorm, Rohypnol, Ronal, Vulbegal | 1, 2 | 1.5 | 0.5–3 | 18–200 | hypnotic | |||||||||||||||
| Flunitrazolam | 0.25, 0.5 | 0.1 | 0.5-1 | 5-13 | hypnotic | ||||||||||||||||
| Flurazepam | Dalmadorm, Dalmane, Fluzepam | 30 | 20-25 | 1–1.5 | 40–250 | hypnotic | |||||||||||||||
| Flutazolam | Coreminal | 4 | 10 | 1-3 | 47-100 | hypnotic | |||||||||||||||
| Flutemazepam | 1 | 0.5-5 | 8-20 | vauthors = Esmailian M, Ahmadi O, Taheri M, Zamani M | title = Comparison of haloperidol and midazolam in restless management of patients referred to the Emergency Department: A double-blinded, randomized clinical trial | journal = Journal of Research in Medical Sciences | volume = 20 | issue = 9 | pages = 844–849 | date = September 2015 | pmc = 6486117 | doi = 10.1002/14651858.CD003079.pub4 | pmid = 29219171 }} | ||||||||
| Flutoprazepam | Restas | 1, 2 | 2.5 | 0.5–9 | 87 | hypnotic, anticonvulsant, muscle relaxant | |||||||||||||||
| Halazepam | Alapryl, Paxipam | 20, 40 | 40 | 3–6 | 15-35 [30-100] | anxiolytic | |||||||||||||||
| Ketazolam | Anxon, Sedotime | 15, 30, 45 | 20 | 2.5–6 | 30-100 [36-200] | anxiolytic | |||||||||||||||
| Loprazolam | Dormonoct, Havlane | 1, 2 | 1.5 | 2–5 | 6–20 | hypnotic | |||||||||||||||
| Lorazepam | Ativan, Lorabenz, Lorenin, Lorsilan, Orfidal, Tavor, Temesta | 0.5, 1, 2, 2.5 | 1 | 2–4 | 10–20 | anxiolytic, anticonvulsant, hypnotic, muscle relaxant | |||||||||||||||
| Lormetazepam | Loramet, Noctamid, Pronoctan | 1, 2 | 1.5 | 0.5–2 | 10-12 | hypnotic, anxiolytic | |||||||||||||||
| Meclonazepam | 6 | anxiolytic | |||||||||||||||||||
| Medazepam | Ansilan, Mezapam, Nobrium, Raporan, Rudotel | 10 | 10 | 4-8 | 36–200 | anxiolytic | |||||||||||||||
| Metizolam | 1, 2, 4 | 2–4 | 12 | anxiolytic | |||||||||||||||||
| Mexazolam | Melex, Sedoxil | 0.5, 1 | 1–2 | anxiolytic | |||||||||||||||||
| Midazolam | Dormicum, Dormonid, Flormidal, Hypnovel, Versed | 7.5, 15 | 10 (oral) | 0.5–1 | 1.8-6 | hypnotic, anticonvulsant | |||||||||||||||
| Nifoxipam | 0.5, 1, 2 | hypnotic | |||||||||||||||||||
| Nimetazepam | Erimin, Lavol | 5 | 2.5-5 | 0.5–3 | 14–30 | hypnotic | |||||||||||||||
| Nitemazepam | 2 | 0.5-5 | 10-27 | hypnotic, anticonvulsant | |||||||||||||||||
| Nitrazepam | Alodorm, Dumolid, Mogadon, Nitrazadon, Pacisyn | 5, 10 | 5 | 0.5–7 | 17–48 | hypnotic, anticonvulsant | |||||||||||||||
| Nitrazolam | 0.5, 1 | hypnotic | |||||||||||||||||||
| Nordazepam | Madar, Stilny | 5, 7.5, 15 | 10-15 | 30–150 | anxiolytic | ||||||||||||||||
| Norflurazepam | 5 | 47-100 | hypnotic | ||||||||||||||||||
| Oxazepam | Alepam, Medopam, Murelax, Noripam, Ox-Pam, Opamox, Oxabenz, Oxapax, Oxascand, Purata, Serax, Serenid, Serepax, Seresta, Sobril | 10, 15, 30, 50 | 30 | 3–4 | 4–11 | anxiolytic | |||||||||||||||
| Phenazepam | Phenazepam, Phenzitat | 1.5–4 | 60 | anxiolytic, anticonvulsant | |||||||||||||||||
| Pinazepam | Domar, Duna | 5, 10 | 40–100 | anxiolytic | |||||||||||||||||
| Prazepam | Centrax, Demetrin, Lysanxia, Prazene | 10, 20, 30 | 15-20 | 2–6 | 36–200 | anxiolytic | |||||||||||||||
| Premazepam | 15 | 2–6 | 10–13 | anxiolytic | |||||||||||||||||
| Pyrazolam | 0.25, 0.5, 1 | 1–1.5 | 16–18 | anxiolytic, amnesic | |||||||||||||||||
| Quazepam | Doral, Quiedorm | 15 | 20 | 1–5 | 39–120 | hypnotic | |||||||||||||||
| Rilmazafone | Rhythmy | 11 | hypnotic | ||||||||||||||||||
| Temazepam | Euhypnos, Normison, Restoril, Temaze, Tenox | 10, 20 | 15-20 | 0.5–3 | 4–11 | hypnotic, anxiolytic, muscle relaxant | |||||||||||||||
| Tetrazepam | Clinoxam, Epsipam, Musaril, Myolastan | 50 | 1–3 | 3–26 | muscle relaxant, anxiolytic | ||||||||||||||||
| Triazolam | Halcion, Notison, Rilamir, Somese | 0.125, 0.25 | 0.5 | 0.5–2 | 2 | hypnotic |
Atypical benzodiazepine receptor ligands
| Drug Name | Common Trade Names | Year approved (US FDA) | Elimination Half-life of Active Metabolite (hours) | Primary Therapeutic Use |
|---|---|---|---|---|
| DMCM | anxiogenic, convulsant | |||
| Flumazenil | Anexate, Lanexat, Mazicon, Romazicon | 1 | antidote | |
| Eszopiclone§ | Lunesta | 2004 | 6 | hypnotic |
| Zaleplon§ | Sonata, Starnoc | 1999 | 1 | hypnotic |
| Zolpidem§ | Ambien, Nytamel, Sanval, Stilnoct, Stilnox, Sublinox (Canada), Xolnox, Zoldem, Zolnod | 1992 | 2.6 | hypnotic |
| Zopiclone§ | Imovane, Rhovane, Ximovan; Zileze; Zimoclone; Zimovane; Zopitan; Zorclone, Zopiklone | 4–6 | hypnotic |
Controversy
In 2015 the UK's House of Commons attempted to get a two to four week limit mandate for prescribing benzodiazepines to replace the two to four week benzodiazepine prescribing guidelines, which are merely recommended.
Binding data and structure-activity relationship

A large number of benzodiazepine derivatives have been synthesised and their structure-activity relationships explored in detail. This chart contains binding data for benzodiazepines and related drugs investigated by Roche up to the late 1990s (though in some cases the compounds were originally synthesised by other companies such as Takeda or Upjohn). Other benzodiazepines are also listed for comparison purposes, but it does not however include binding data for;
- Benzodiazepines developed in the former Soviet Union (e.g. phenazepam, gidazepam etc.)
- Benzodiazepines predominantly used only in Japan (e.g. nimetazepam, flutoprazepam etc.)
- 4,5-cyclised benzodiazepines (e.g. ketazolam, cloxazolam etc.), and other compounds not researched by Roche
- Benzodiazepines developed more recently (e.g. remimazolam, QH-ii-066, Ro48-6791 etc.)
- "Designer" benzodiazepines for which in vitro binding data are unavailable (e.g. flubromazolam, pyrazolam etc.) While binding or activity data are available for most of these compounds also, the assay conditions vary between sources, meaning that in many cases the values are not suitable for a direct comparison. Many older sources used animal measures of activity (i.e. sedation or anticonvulsant activity) but did not measure in vitro binding to benzodiazepine receptors. See for instance Table 2 vs Table 11 in the Chem Rev paper, Table 2 lists in vitro pIC50 values matching those below, while Table 11 has pEC50 values derived from in vivo assays in mice, which show the same activity trends but cannot be compared directly, and includes data for compounds such as diclazepam and flubromazepam which are not available in the main data set.
Also note;
- IC50 / pIC50 values represent binding affinity only and do not reflect efficacy or pharmacokinetics, and some compounds listed are GABAA antagonists rather than agonists (e.g. flumazenil).
- Low IC50 or high pIC50 values indicate tighter binding (pIC50 of 8.0 = IC50 of 10nM, pIC50 of 9.0 = IC50 of 1nM, etc.)
- These are non subtype selective IC50 values averaged across all GABAA receptor subtypes, so subtype selective compounds with strong binding at one subtype but weak at others will appear unusually weak due to averaging of binding values (see e.g. CL-218,872)
- † indicates a predicted value from in silico modelling.
- Finally, note that the benzodiazepine core is a privileged scaffold, which has been used to derive drugs with diverse activity that is not limited to the GABAA modulatory action of the classical benzodiazepines, such as devazepide and tifluadom, however these have not been included in the list below. 2,3-benzodiazepines such as tofisopam are also not listed, as these act primarily as AMPA receptor modulators, and are inactive at GABAA receptors.
Table
| Chemical structure | Code | pIC50 / IC50 | Chemical name | PubChem | CAS number | |
|---|---|---|---|---|---|---|
| [[File:Ro05-3061_structure.png | 120px]] | Ro05-3061 | 7.3979 / 40nM | 7-fluoro-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [75849](https://pubchem.ncbi.nlm.nih.gov/compound/75849) | 2648-00-2 |
| [[File:Ro05-4865_structure.png | 120px]] | Ro05-4865 | 7.7696 / 17nM | 7-fluoro-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366179](https://pubchem.ncbi.nlm.nih.gov/compound/44366179) | |
| [[File:Ro05-6820_structure.png | 120px]] | Ro05-6820 | 8.1308 / 7.4nM | 7-fluoro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366116](https://pubchem.ncbi.nlm.nih.gov/compound/44366116) | |
| [[File:Ro05-6822_structure.png | 120px]] | Ro05-6822 | 8.2924 / 5.1nM | 7-fluoro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [23275675](https://pubchem.ncbi.nlm.nih.gov/compound/23275675) | 2024-34-2 |
| [[File:Flubromazepam isomer.svg | 120px]] | Iso-flubromazepam | 7-fluoro-5-(2-bromophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [15292433](https://pubchem.ncbi.nlm.nih.gov/compound/15292433) | 153873-96-2 | |
| [[File:Nordazepam.svg | 120px]] | Nordazepam | 8.0269 / 9.4nM | 7-chloro-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [2997](https://pubchem.ncbi.nlm.nih.gov/compound/2997) | 1088-11-5 |
| [[File:Diazepam structure.svg | 120px]] | Diazepam | 8.0915 / 8.1nM | 7-chloro-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3016](https://pubchem.ncbi.nlm.nih.gov/compound/3016) | 439-14-5 |
| [[File:Desalkylflurazepam.svg | 120px]] | Norflurazepam (Ro05-3367) | 8.699 | 7-chloro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [4540](https://pubchem.ncbi.nlm.nih.gov/compound/4540) | 2886-65-9 |
| [[File:Fludiazepam.svg | 120px]] | Fludiazepam | 7-chloro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3369](https://pubchem.ncbi.nlm.nih.gov/compound/3369) | 3900-31-0 | |
| [[File:Ro07-3953_structure.png | 120px]] | Ro07-3953 | 8.7959 / 1.6nM | 7-chloro-5-(2,6-difluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [23275763](https://pubchem.ncbi.nlm.nih.gov/compound/23275763) | |
| [[File:Difludiazepam Structure.svg | 120px]] | Difludiazepam (Ro07-4065) | 8.3872 / 4.1nM | 7-chloro-5-(2,6-difluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366236](https://pubchem.ncbi.nlm.nih.gov/compound/44366236) | 39080-67-6 |
| [[File:Delorazepam 200.svg | 120px]] | Delorazepam | 8.7447 / 1.8nM | 7-chloro-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [17925](https://pubchem.ncbi.nlm.nih.gov/compound/17925) | 2894-67-9 |
| [[File:Diclazepam structure.svg | 120px]] | Diclazepam (Ro05-3448) | 7.8 † | 7-chloro-5-(2-chlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [76168](https://pubchem.ncbi.nlm.nih.gov/compound/76168) | 2894-68-0 |
| [[File:Ro5-4864.svg | 120px]] | Ro05-4864 | TSPO ligand | 7-chloro-5-(4-chlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [1688](https://pubchem.ncbi.nlm.nih.gov/compound/1688) | 14439-61-3 |
| [[File:Ro07-5193_structure.png | 120px]] | Ro07-5193 | 8.5229 | 7-chloro-5-(2-chloro-6-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366219](https://pubchem.ncbi.nlm.nih.gov/compound/44366219) | |
| [[File:Ro22-3294_structure.png | 120px]] | Ro22-3294 | 8.1549 | 7-chloro-5-(2,6-dichlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [12790028](https://pubchem.ncbi.nlm.nih.gov/compound/12790028) | |
| [[File:Ro07-5220_structure.png | 120px]] | Ro07-5220 | 8.2596 | 7-chloro-5-(2,6-dichlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [9975396](https://pubchem.ncbi.nlm.nih.gov/compound/9975396) | 30144-88-8 |
| [[File:Desalkylgidazepam.svg | 120px]] | 7-BPDBD | 7.8 † | 7-bromo-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [76167](https://pubchem.ncbi.nlm.nih.gov/compound/76167) | 2894-61-3 |
| [[File:QH-II-063_structure.png | 120px]] | QH-II-063 | 7-bromo-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [627432](https://pubchem.ncbi.nlm.nih.gov/compound/627432) | 28611-28-1 | |
| [[File:Phenazepam.svg | 120px]] | Phenazepam | 8.4 † | 7-bromo-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [40113](https://pubchem.ncbi.nlm.nih.gov/compound/40113) | 51753-57-2 |
| [[File:Flubromazepam.svg | 120px]] | Flubromazepam (JYI-42) | 7.6 † | 7-bromo-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [12947024](https://pubchem.ncbi.nlm.nih.gov/compound/12947024) | 2647-50-9 |
| [[File:Flubrometazepam.svg | 120px]] | Flubrometazepam | 7-bromo-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [135809](https://pubchem.ncbi.nlm.nih.gov/compound/135809) | 86890-79-1 | |
| [[File:SH-I-048A_structure.png | 120px]] | SH-I-048A | (3S)-7-bromo-5-(2-fluorophenyl)-3-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [49850464](https://pubchem.ncbi.nlm.nih.gov/compound/49850464) | 872874-11-8 | |
| [[File:Gidazepam.svg | 120px]] | Gidazepam | 6.4 † | 2-(7-bromo-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e] [1,4]diazepin-1-yl)acetohydrazide | [121919](https://pubchem.ncbi.nlm.nih.gov/compound/121919) | 129186-29-4 |
| [[File:Ro13-3780_structure.png | 120px]] | Ro13-3780 | 8.6198 | 7-bromo-5-(2,6-difluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [9975396](https://pubchem.ncbi.nlm.nih.gov/compound/9975396) | 103380-73-0 |
| [[File:Ro07-9749_structure.png | 120px]] | Ro07-9749 | 7-iodo-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3082318](https://pubchem.ncbi.nlm.nih.gov/compound/3082318) | 30843-56-2 | |
| [[File:Ro07-9957_structure.png | 120px]] | Ro07-9957 | 8.5376 | 7-iodo-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [118749](https://pubchem.ncbi.nlm.nih.gov/compound/118749) | |
| [[File:Triflunordazepam.svg | 120px]] | Ro05-2904 | 7.8861 / 13nM | 7-trifluoromethyl-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [16795](https://pubchem.ncbi.nlm.nih.gov/compound/16795) | 2285-16-7 |
| [[File:Ro14-3074_structure.png | 120px]] | Ro14-3074 | 8.2757 / 5.3nM | 7-azido-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Nitrazepam.svg | 120px]] | Nitrazepam | 8.0 / 10nM | 7-nitro-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [4506](https://pubchem.ncbi.nlm.nih.gov/compound/4506) | 146-22-5 |
| [[File:Nimetazepam.svg | 120px]] | Nimetazepam | 7-nitro-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [4496](https://pubchem.ncbi.nlm.nih.gov/compound/4496) | 2011-67-8 | |
| [[File:Desmethylflunitrazepam.svg | 120px]] | Ro05-4435 | 8.829 / 1.5nM | 7-nitro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [520217](https://pubchem.ncbi.nlm.nih.gov/compound/520217) | 2558-30-7 |
| [[File:Flunitrazepam structure.svg | 120px]] | Flunitrazepam | 8.4202 / 3.8nM | 7-nitro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3380](https://pubchem.ncbi.nlm.nih.gov/compound/3380) | 1622-62-4 |
| [[File:Clonazepam 200.svg | 120px]] | Clonazepam | 8.7447 / 1.8nM | 7-nitro-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [2802](https://pubchem.ncbi.nlm.nih.gov/compound/2802) | 1622-61-3 |
| [[File:Ro05-4082_structure.png | 120px]] | Ro05-4082 | 8.6576 | 7-nitro-5-(2-chlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [528222](https://pubchem.ncbi.nlm.nih.gov/compound/528222) | 5527-71-9 |
| [[File:Ro05-3590_structure.png | 120px]] | Ro05-3590 | 8.4559 / 3.5nM | 7-nitro-5-[2-(trifluoromethyl)phenyl]-1H-benzo[e] [1,4]diazepin-2(3H)-one | [15024](https://pubchem.ncbi.nlm.nih.gov/compound/15024) | 1427-45-8 |
| [[File:QH-146_structure.png | 120px]] | QH-146 | 7-nitro-5-(2-nitrophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44383992](https://pubchem.ncbi.nlm.nih.gov/compound/44383992) | ||
| [[File:Ro20-7736_structure.png | 120px]] | Ro20-7736 | 7.0177 / 96nM | 7-hydroxyamino-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro05-3072_structure.png | 120px]] | Ro05-3072 | 6.4134 / 386nM | 7-amino-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [78641](https://pubchem.ncbi.nlm.nih.gov/compound/78641) | 4928-02-3 |
| [[File:Ro05-4318_structure.png | 120px]] | Ro05-4318 | 6.3372 / 460nM | 7-amino-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [23275339](https://pubchem.ncbi.nlm.nih.gov/compound/23275339) | 4959-16-4 |
| [[File:Ro20-1815_structure.png | 120px]] | Ro20-1815 | 7.1871 / 65nM | 7-amino-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [92294](https://pubchem.ncbi.nlm.nih.gov/compound/92294) | 34084-50-9 |
| [[File:Ro05-4619_structure.png | 120px]] | Ro05-4619 | 7.1249 / 75nM | 7-amino-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [188298](https://pubchem.ncbi.nlm.nih.gov/compound/188298) | 4959-17-5 |
| Ro05-3308 | IC50 1000nM | N-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e] [1,4]diazepin-7-yl)acetamide | ||||
| Ro12-6377 | 7.1249 / 455nM | 1-(5-(2-fluorophenyl)-1-methyl-2-oxo-2,5-dihydro-1H-benzo[e] [1,4]diazepin-7-yl)-3-methylurea | ||||
| [[File:Ro05-9090_structure.png | 120px]] | Ro05-9090 | IC50 1000nM | 7-(aminomethyl)-1-methyl-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro05-3343_structure.png | 120px]] | Ro05-3343 | IC50 1000nM | N,N-dimethyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e] [1,4]diazepine-7-sulfonamide | [214460](https://pubchem.ncbi.nlm.nih.gov/compound/214460) | 12037-79-5 |
| [[File:Ro05-4528_structure.png | 120px]] | Ro05-4528 | 6.4202 / 380nM | 7-cyano-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro20-2541_structure.png | 120px]] | Ro20-2541 | 7.5229 / 30nM | 7-cyano-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro20-2533_structure.png | 120px]] | Ro20-2533 | 7.4437 / 36nM | 7-ethyl-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [10264786](https://pubchem.ncbi.nlm.nih.gov/compound/10264786) | |
| [[File:Ro20-5747_structure.png | 120px]] | Ro20-5747 | 7.6198 / 24nM | 7-vinyl-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366036](https://pubchem.ncbi.nlm.nih.gov/compound/44366036) | |
| [[File:QH-II-66.svg | 120px]] | QH-ii-066 | 7.4 † | 7-ethynyl-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [9838431](https://pubchem.ncbi.nlm.nih.gov/compound/9838431) | 183239-39-6 |
| [[File:OMB-18_structure.png | 120px]] | OMB-18 | 7-ethynyl-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [89276170](https://pubchem.ncbi.nlm.nih.gov/compound/89276170) | ||
| [[File:XLI-352_structure.png | 120px]] | XLI-352 | 7-ethynyl-5-(2-chlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [21065236](https://pubchem.ncbi.nlm.nih.gov/compound/21065236) | ||
| [[File:Ro20-5397_structure.png | 120px]] | Ro20-5397 | 7.3665 / 43nM | 7-formyl-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro20-3053_structure.png | 120px]] | Ro20-3053 | 7.7447 / 18nM | 7-acetyl-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [21828109](https://pubchem.ncbi.nlm.nih.gov/compound/21828109) | |
| [[File:Ro05-2921_structure.png | 120px]] | Ro05-2921 | 6.4559 / 350nM | 5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [76175](https://pubchem.ncbi.nlm.nih.gov/compound/76175) | 2898-08-0 |
| [[File:Ro05-3663_structure.png | 120px]] | Ro05-3663 | IC50 1000nM | 5-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [5080](https://pubchem.ncbi.nlm.nih.gov/compound/5080) | 70656-87-0 |
| [[File:Ro05-4336_structure.png | 120px]] | Ro05-4336 | 7.6778 / 21nM | 5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [13292074](https://pubchem.ncbi.nlm.nih.gov/compound/13292074) | |
| [[File:Ro07-4419_structure.png | 120px]] | Ro07-4419 | 7.7212 / 19nM | 5-(2,6-difluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366255](https://pubchem.ncbi.nlm.nih.gov/compound/44366255) | |
| [[File:Ro05-4520_structure.png | 120px]] | Ro05-4520 | 7.8539 / 14nM | 5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [193319](https://pubchem.ncbi.nlm.nih.gov/compound/193319) | 844-11-1 |
| [[File:Ro05-4608_structure.png | 120px]] | Ro05-4608 | 8.4202 | 5-(2-chlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [10469149](https://pubchem.ncbi.nlm.nih.gov/compound/10469149) | |
| [[File:Ro05-3546_structure.png | 120px]] | Ro05-3546 | 6.4949 / 320nM | 6-chloro-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [14590445](https://pubchem.ncbi.nlm.nih.gov/compound/14590445) | |
| [[File:Ro13-0699_structure.png | 120px]] | Ro13-0699 | 6.8239 / 150nM | 6-chloro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44377764](https://pubchem.ncbi.nlm.nih.gov/compound/44377764) | |
| [[File:Ro07-6198_structure.png | 120px]] | Ro07-6198 | 7.5528 / 28nM | 8-chloro-5-(2,6-difluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [23275762](https://pubchem.ncbi.nlm.nih.gov/compound/23275762) | |
| [[File:Ro20-8895_structure.png | 120px]] | Ro20-8895 | 7.7212 / 19nM | 8-methyl-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366169](https://pubchem.ncbi.nlm.nih.gov/compound/44366169) | |
| [[File:Ro13-0593_structure.png | 120px]] | Ro13-0593 | 7.1427 / 72nM | 9-chloro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro13-0882_structure.png | 120px]] | Ro13-0882 | IC50 300nM | 6,8-dichloro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro22-6762_structure.png | 120px]] | Ro22-6762 | 7.3979 / 40nM | 7,8-dichloro-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366089](https://pubchem.ncbi.nlm.nih.gov/compound/44366089) | |
| [[File:Ro20-8065_structure.png | 120px]] | Ro20-8065 | 8.4437 / 3.6nM | 7,8-dichloro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [10358803](https://pubchem.ncbi.nlm.nih.gov/compound/10358803) | 88695-06-1 |
| [[File:Ro20-8552_structure.png | 120px]] | Ro20-8552 | 7.8539 / 14nM | 7-methyl-8-chloro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [44366138](https://pubchem.ncbi.nlm.nih.gov/compound/44366138) | |
| [[File:Ro05-2750_structure.png | 120px]] | Ro05-2750 | 7.4318 / 37nM | 6,8-dichloro-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro14-2312_structure.png | 120px]] | Ro14-2312 | IC50 1000nM | 6-amino-8-chloro-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| Ro07-3609 | 7.284 | |||||
| [[File:Ro11-8125_structure.png | 120px]] | Ro11-8125 | 7.4318 / 37nM | 5-(2-chlorophenyl)-1H-thieno[2,3-e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro08-6739_structure.png | 120px]] | Ro08-6739 | IC50 70nM | 7-chloro-5-phenyl-1H-thieno[2,3-e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro09-9212_structure.png | 120px]] | Ro09-9212 | 8.4089 / 3.9nM | 7-chloro-5-(2-chlorophenyl)-1H-thieno[2,3-e] [1,4]diazepin-2(3H)-one | [135721042](https://pubchem.ncbi.nlm.nih.gov/compound/135721042) | |
| [[File:Ro10-2643_structure.png | 120px]] | Ro10-2643 | IC50 9.4nM | 7-chloro-5-(2-chlorophenyl)-1H-thieno[3,2-e] [1,4]diazepin-2(3H)-one | ||
| [[File:Clotiazepam.svg | 120px]] | Clotiazepam | 7-ethyl-5-(2-chlorophenyl)-1-methyl-1H-thieno[2,3-e] [1,4]diazepin-2(3H)-one | [2811](https://pubchem.ncbi.nlm.nih.gov/compound/2811) | 33671-46-4 | |
| [[File:Bentazepam.svg | 120px]] | Bentazepam | 8.5 † | 5-phenyl-3,5a,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e] [1,4]diazepin-2(3H)-one | [34592](https://pubchem.ncbi.nlm.nih.gov/compound/34592) | 29462-18-8 |
| [[File:Lopirazepam.svg | 120px]] | Lopirazepam | 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-pyrido[3,2-e] [1,4]diazepin-2-one | [68672](https://pubchem.ncbi.nlm.nih.gov/compound/68672) | 42863-81-0 | |
| [[File:Premazepam.svg | 120px]] | Premazepam | 6.7696 / 170nM | 6,7-dimethyl-5-phenyl-3,7-dihydropyrrolo[3,4-e] [1,4]diazepin-2(1H)-one | [72104](https://pubchem.ncbi.nlm.nih.gov/compound/72104) | 57435-86-6 |
| [[File:Ripazepam.svg | 120px]] | Ripazepam | 1-ethyl-3-methyl-8-phenyl-4,6-dihydropyrazolo[4,3-e] [1,4]diazepin-5(1H)-one | [33474](https://pubchem.ncbi.nlm.nih.gov/compound/33474) | 26308-28-1 | |
| [[File:Zolazepam.svg | 120px]] | Zolazepam | 1,3,8-trimethyl-4-(2-fluorophenyl)-6,8-dihydropyrazolo[3,4-e] [1,4]diazepin-7(1H)-one | [35775](https://pubchem.ncbi.nlm.nih.gov/compound/35775) | 31352-82-6 | |
| [[File:Zomebazam structure.svg | 120px]] | Zomebazam | 8.1 † | 1,3,8-trimethyl-4-phenyl-6,8-dihydropyrazolo[4,3-b] [1,4]diazepine-5,7(1H,4H)-dione | [132677](https://pubchem.ncbi.nlm.nih.gov/compound/132677) | 78466-70-3 |
| [[File:Ro17-2221_structure.png | 120px]] | Ro17-2221 | 6.585 / 260nM | 1-(2-aminoethyl)-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| Ro07-5096 | IC50 1000nM | 2-(7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1H-benzo[e] [1,4]diazepin-1-yl)acetic acid | ||||
| Ro08-3026 | 7.2007 | |||||
| [[File:Halazepam.svg | 120px]] | Halazepam | 7.0362 / 92nM | 7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [31640](https://pubchem.ncbi.nlm.nih.gov/compound/31640) | 23092-17-3 |
| [[File:Quazepam.svg | 120px]] | Quazepam | 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-thione | [4999](https://pubchem.ncbi.nlm.nih.gov/compound/4999) | 36735-22-5 | |
| [[File:Fletazepam.svg | 120px]] | Fletazepam | 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-1H-benzo[e] [1,4]diazepine | [36834](https://pubchem.ncbi.nlm.nih.gov/compound/36834) | 34482-99-0 | |
| [[File:Pinazepam.svg | 120px]] | Pinazepam | 7.0339 / 92.5nM | 7-chloro-5-phenyl-1-(prop-2-yn-1-yl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [40391](https://pubchem.ncbi.nlm.nih.gov/compound/40391) | 52463-83-9 |
| [[File:Prazepam.svg | 120px]] | Prazepam | IC50 110nM | 7-chloro-5-phenyl-1-cyclopropylmethyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [4890](https://pubchem.ncbi.nlm.nih.gov/compound/4890) | 2955-38-6 |
| [[File:Flutoprazepam.svg | 120px]] | Flutoprazepam | 6.6 † | 7-chloro-5-(2-fluorophenyl)-1-cyclopropylmethyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3400](https://pubchem.ncbi.nlm.nih.gov/compound/3400) | 25967-29-7 |
| [[File:Cloniprazepam.svg | 120px]] | Cloniprazepam | 7.8 † | 7-nitro-5-(2-chlorophenyl)-1-cyclopropylmethyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro20-1310_structure.png | 120px]] | Ro20-1310 | 6.2076 / 620nM | 7-chloro-5-phenyl-1-(t-butyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Fosazepam.svg | 120px]] | Fosazepam | 7-chloro-5-phenyl-1-(dimethylphosphorylmethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [37114](https://pubchem.ncbi.nlm.nih.gov/compound/37114) | 35322-07-7 | |
| [[File:Iclazepam.svg | 120px]] | Iclazepam | 7-chloro-5-phenyl-1-[2-(cyclopropylmethoxy)ethyl]-1H-benzo[e] [1,4]diazepin-2(3H)-one | [68777](https://pubchem.ncbi.nlm.nih.gov/compound/68777) | 57916-70-8 | |
| [[File:Tolufazepam.svg | 120px]] | Tolufazepam | 7-chloro-5-(2-chlorophenyl)-1-[2-(4-methylphenyl)sulfonylethyl]-1H-benzo[e] [1,4]diazepin-2(3H)-one | [65647](https://pubchem.ncbi.nlm.nih.gov/compound/65647) | 86273-92-9 | |
| [[File:Elfazepam.svg | 120px]] | Elfazepam | 6.9 † | 7-chloro-5-(2-fluorophenyl)-1-(2-ethylsulfonylethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [65445](https://pubchem.ncbi.nlm.nih.gov/compound/65445) | 52042-01-0 |
| [[File:Reclazepam.svg | 120px]] | Reclazepam | 2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]-1,3-oxazol-4(5H)-one | [3052777](https://pubchem.ncbi.nlm.nih.gov/compound/3052777) | 76053-16-2 | |
| [[File:Ro07-1986_structure.png | 120px]] | Ro07-1986 | 8.0809 / 8.3nM | 1-(2-aminoethyl)-7-chloro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Flurazepam.svg | 120px]] | Flurazepam | 7.8297 | 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | [3393](https://pubchem.ncbi.nlm.nih.gov/compound/3393) | 17617-23-1 |
| [[File:Ro07-2750_structure.png | 120px]] | Ro07-2750 | 7.6108 / 24.5nM | 7-chloro-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Motrazepam structure.svg | 120px]] | Motrazepam | IC50 430nM | 1-(methoxymethyl)-7-nitro-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [65764](https://pubchem.ncbi.nlm.nih.gov/compound/65764) | 29442-58-8 |
| Ro08-9013 | 7.3716 | |||||
| [[File:Proflazepam.svg | 120px]] | Proflazepam | 6.8539 / 140nM | 7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3050433](https://pubchem.ncbi.nlm.nih.gov/compound/3050433) | 52829-30-8 |
| [[File:Ro22-4683_structure.png | 120px]] | Ro22-4683 | 6.5229 / 300nM | 7-nitro-5-(2-fluorophenyl)-1-(t-butyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro15-8852_structure.png | 120px]] | Ro15-8852 | 6.1391 / 726nM | 5-(2-chlorophenyl)-4-methyl-7-nitro-4,5-dihydro-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Chlordiazepoxide.svg | 120px]] | Chlordiazepoxide | 6.4535 / 352nM | 7-chloro-2-methylamino-5-phenyl-3H-benzo[e] [1,4]diazepine-4-oxide | [2712](https://pubchem.ncbi.nlm.nih.gov/compound/2712) | 58-25-3 |
| [[File:Cyprazepam.svg | 120px]] | Cyprazepam | 7-chloro-N-(cyclopropylmethyl)-4-hydroxy-5-phenyl-3H-benzo[e] [1,4]diazepin-2-imine | [27452](https://pubchem.ncbi.nlm.nih.gov/compound/27452) | 15687-07-7 | |
| [[File:Uldazepam.svg | 120px]] | Uldazepam | 7.6 † | 7-chloro-5-(2-chlorophenyl)-N-prop-2-enoxy-3H-benzo[e] [1,4]diazepin-2-amine | [34274](https://pubchem.ncbi.nlm.nih.gov/compound/34274) | 28546-58-9 |
| [[File:Demoxepam.svg | 120px]] | Demoxepam | 6.5086 / 310nM | 7-chloro-1,3-dihydro-5-phenyl-2H-benzo[e] [1,4]diazepin-2-one-4-oxide | [13756](https://pubchem.ncbi.nlm.nih.gov/compound/13756) | 963-39-3 |
| [[File:Medazepam.svg | 120px]] | Medazepam | IC50 870nM | 7-chloro-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepine | [4041](https://pubchem.ncbi.nlm.nih.gov/compound/4041) | 2898-12-6 |
| [[File:Tuclazepam.svg | 120px]] | Tuclazepam | 7.7 † | 7-chloro-5-(2-chlorophenyl)-2-(hydroxymethyl)-1-methyl-2,3-dihydro-1H-benzo[e] [1,4]diazepine | [3050405](https://pubchem.ncbi.nlm.nih.gov/compound/3050405) | 51037-88-8 |
| [[File:Metaclazepam.svg | 120px]] | Metaclazepam | 7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-2,3-dihydro-1H-benzo[e] [1,4]diazepine | [71272](https://pubchem.ncbi.nlm.nih.gov/compound/71272) | 84031-17-4 | |
| [[File:Sulazepam.svg | 120px]] | Sulazepam | 7.7 † | 7-chloro-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-thione | [17931](https://pubchem.ncbi.nlm.nih.gov/compound/17931) | 2898-13-7 |
| [[File:Tetrazepam.svg | 120px]] | Tetrazepam | 7.4685 / 34nM | 7-chloro-5-(cyclohexen-1-yl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [25215](https://pubchem.ncbi.nlm.nih.gov/compound/25215) | 10379-14-3 |
| [[File:Nortetrazepam.svg | 120px]] | Nortetrazepam | IC50 34nM | 7-chloro-5-(cyclohexen-1-yl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [166581](https://pubchem.ncbi.nlm.nih.gov/compound/166581) | 10379-11-0 |
| [[File:Menitrazepam.svg | 120px]] | Menitrazepam | 7-nitro-5-(cyclohexen-1-yl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [189875](https://pubchem.ncbi.nlm.nih.gov/compound/189875) | 28781-64-8 | |
| [[File:Ro05-3328_structure.png | 120px]] | Ro05-3328 | 7.0605 / 87nM | 7-chloro-5-cyclohexyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Clazolam.svg | 120px]] | Clazolam | 8.1 † | 2-chloro-5-methyl-5,9,10,14b-tetrahydroisoquino[2,1-d] [1,4]benzodiazepin-6(7H)-one | [24107](https://pubchem.ncbi.nlm.nih.gov/compound/24107) | 7492-29-7 |
| [[File:Bromazepam.svg | 120px]] | Bromazepam | 7.7447 / 18nM | 7-bromo-5-(pyridin-2-yl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [2441](https://pubchem.ncbi.nlm.nih.gov/compound/2441) | 1812-30-2 |
| [[File:Methylbromazepam.svg | 120px]] | Methylbromazepam | 7-bromo-5-(pyridin-2-yl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [630183](https://pubchem.ncbi.nlm.nih.gov/compound/630183) | 1812-33-5 | |
| [[File:diazepam-pyridazine_structure.png | 120px]] | Pyridazino-diazepam | 7-chloro-5-(pyridazin-3-yl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | |||
| [[File:Ro5-3335_structure.png | 120px]] | Ro5-3335 | 7-Chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-2H-1,4-benzodiazepin-2-one | [64983](https://pubchem.ncbi.nlm.nih.gov/compound/64983) | ||
| [[File:nordazepam-pyrazole.svg | 120px]] | SCHEMBL9684958 | 7-chloro-5-(1H-pyrazol-5-yl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [21738192](https://pubchem.ncbi.nlm.nih.gov/compound/21738192) | ||
| [[File:Compound-6a_structure.png | 120px]] | Compound 6a | 9.5 † | 7-chloro-5-(3,5-dimethyl-4H-1,2,4-triazol-4-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | ||
| [[File:JC-184.svg | 120px]] | JC-184 | 7-bromo-5-(2-thienyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [21065240](https://pubchem.ncbi.nlm.nih.gov/compound/21065240) | ||
| [[File:BDBM50083903_structure.png | 120px]] | BDBM50083903 | 7-chloro-5-(2-furanyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [10423506](https://pubchem.ncbi.nlm.nih.gov/compound/10423506) | ||
| Ro05-5605 | 6.5376 | |||||
| Ro11-3129 | 8.1871 | (+)-2-amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]propanamide | [21413751](https://pubchem.ncbi.nlm.nih.gov/compound/21413751) | 65607-70-7 | ||
| Ro03-7355 | 6.3768 | |||||
| [[File:Ro11-4878_structure.png | 120px]] | Ro11-4878 | 8.4559 / 3.5nM | 7-chloro-5-(2-fluorophenyl)-3-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Meclonazepam structure.svg | 120px]] | Meclonazepam | 8.9208 / 1.2nM | (3S)-7-nitro-5-(2-chlorophenyl)-3-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3033985](https://pubchem.ncbi.nlm.nih.gov/compound/3033985) | 58662-84-3 |
| [[File:Ro11-6896_structure.png | 120px]] | Ro11-6896 | 8.1549 / 7nM | 7-nitro-5-(2-fluorophenyl)-1,3-dimethyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Ro06-7263_structure.png | 120px]] | Ro06-7263 | 7.3098 / 49nM | 1,7-dichloro-5-phenyl-3-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Oxazepam.svg | 120px]] | Oxazepam | 7.7447 / 18nM | 7-chloro-3-hydroxy-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [4616](https://pubchem.ncbi.nlm.nih.gov/compound/4616) | 604-75-1 |
| [[File:Temazepam.svg | 120px]] | Temazepam | 7.7959 / 16nM | 7-chloro-3-hydroxy-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [5391](https://pubchem.ncbi.nlm.nih.gov/compound/5391) | 846-50-4 |
| [[File:Lorazepam.svg | 120px]] | Lorazepam | 8.4559 / 3.5nM | 7-chloro-3-hydroxy-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3958](https://pubchem.ncbi.nlm.nih.gov/compound/3958) | 846-49-1 |
| [[File:Lormetazepam.svg | 120px]] | Lormetazepam | 7-chloro-3-hydroxy-5-(2-chlorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [13314](https://pubchem.ncbi.nlm.nih.gov/compound/13314) | 848-75-9 | |
| [[File:Flutemazepam structure.svg | 120px]] | Flutemazepam | 8.1 † | 7-chloro-3-hydroxy-5-(2-fluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [40344](https://pubchem.ncbi.nlm.nih.gov/compound/40344) | 52391-89-6 |
| [[File:Cinolazepam.svg | 120px]] | Cinolazepam | 7-chloro-3-hydroxy-5-(2-fluorophenyl)-1-(2-cyanoethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3033621](https://pubchem.ncbi.nlm.nih.gov/compound/3033621) | 75696-02-5 | |
| [[File:Doxefazepam.svg | 120px]] | Doxefazepam | 7-chloro-3-hydroxy-5-(2-fluorophenyl)-1-(2-hydroxyethyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [38668](https://pubchem.ncbi.nlm.nih.gov/compound/38668) | 40762-15-0 | |
| [[File:Nifoxipam.svg | 120px]] | Nifoxipam | 8.5 † | 7-nitro-3-hydroxy-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [3058221](https://pubchem.ncbi.nlm.nih.gov/compound/3058221) | 74723-10-7 |
| [[File:Nitemazepam.svg | 120px]] | Nitemazepam | 7-nitro-3-hydroxy-5-phenyl-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [12362353](https://pubchem.ncbi.nlm.nih.gov/compound/12362353) | 40762-03-6 | |
| [[File:3-Hydroxyphenazepam.svg | 120px]] | [3-Hydroxyphenazepam](3-hydroxyphenazepam) | 8.7 † | 7-bromo-3-hydroxy-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [125820](https://pubchem.ncbi.nlm.nih.gov/compound/125820) | 70030-11-4 |
| [[File:Cinazepam.svg | 120px]] | Cinazepam | 7-bromo-3-succinyloxy-5-(2-chlorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | [629281](https://pubchem.ncbi.nlm.nih.gov/compound/629281) | 172986-25-3 | |
| [[File:Pivoxazepam.svg | 120px]] | Pivoxazepam | 7-chloro-3-pivalyloxy-5-phenyl-1H-benzo[e] [1,4]diazepin-2(3H)-one | [68722](https://pubchem.ncbi.nlm.nih.gov/compound/68722) | 55299-10-0 | |
| [[File:Camazepam.svg | 120px]] | Camazepam | 6.0458 | 7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e] [1,4]diazepin-3-yl N,N-dimethylcarbamate | [37367 ](https://pubchem.ncbi.nlm.nih.gov/compound/37367) | 36104-80-0 |
| [[File:Clorazepate.svg | 120px]] | Clorazepate | IC50 59nM | 7-chloro-2-oxo-5-phenyl-1H-benzo[e] [1,4]diazepine-3-carboxylic acid | [2809](https://pubchem.ncbi.nlm.nih.gov/compound/2809) | 23887-31-2 |
| [[File:Nitrazepate structure.svg | 120px]] | Nitrazepate | 7-nitro-2-oxo-5-phenyl-1H-benzo[e] [1,4]diazepine-3-carboxylic acid | [21740](https://pubchem.ncbi.nlm.nih.gov/compound/21740) | 5571-84-6 | |
| [[File:Ethyl carfluzepate.svg | 120px]] | Ethyl carfluzepate | 8.0 † | ethyl 7-chloro-5-(2-fluorophenyl)-1-(methylcarbamoyl)-2-oxo-3H-benzo[e] [1,4]diazepine-3-carboxylate | [68856](https://pubchem.ncbi.nlm.nih.gov/compound/68856) | 65400-85-3 |
| [[File:Ethyl dirazepate.svg | 120px]] | Ethyl dirazepate | 7.5 † | ethyl 7-chloro-5-(2-chlorophenyl)-2-oxo-3H-benzo[e] [1,4]diazepine-3-carboxylate | [208941](https://pubchem.ncbi.nlm.nih.gov/compound/208941) | 23980-14-5 |
| [[File:Ethyl loflazepate.svg | 120px]] | Ethyl loflazepate | ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-3H-benzo[e] [1,4]diazepine-3-carboxylate | [3299](https://pubchem.ncbi.nlm.nih.gov/compound/3299) | 29177-84-2 | |
| [[File:Carburazepam.svg | 120px]] | Carburazepam | 7.9 † | 7-chloro-1-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4H-benzo[e] [1,4]diazepine-4-carboxamide | [68787](https://pubchem.ncbi.nlm.nih.gov/compound/68787) | 59009-93-7 |
| [[File:Ro20-7078_structure.png | 120px]] | Ro20-7078 | 8.2757 / 5.3nM | 3,7-dichloro-5-(2-fluorophenyl)-1H-benzo[e] [1,4]diazepin-2(3H)-one | ||
| [[File:Clobazam structure.svg | 120px]] | Clobazam | 6.8861 / 130nM | 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione | [2789](https://pubchem.ncbi.nlm.nih.gov/compound/2789) | 22316-47-8 |
| [[File:Desmethylclobazam_structure.png | 120px]] | Desmethylclobazam | 6.6778 / 210nM | 7-chloro-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione | ||
| [[File:Triflubazam.svg | 120px]] | Triflubazam | 8.4 † | 7-trifluoromethyl-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione | [2789](https://pubchem.ncbi.nlm.nih.gov/compound/2789) | 22316-47-8 |
| [[File:Lofendazam.svg | 120px]] | Lofendazam | 7-chloro-5-phenyl-1,3,4,5-tetrahydro-4H-1,5-benzodiazepin-4-one | [71709](https://pubchem.ncbi.nlm.nih.gov/compound/71709) | 29176-29-2 | |
| [[File:Arfendazam.svg | 120px]] | Arfendazam | 8.3 † | ethyl 7-chloro-4-oxo-5-phenyl-2,3-dihydro-1,5-benzodiazepine-1-carboxylate | [65803](https://pubchem.ncbi.nlm.nih.gov/compound/65803) | 37669-57-1 |
| [[File:CP-1414S.svg | 120px]] | CP-1414S | 7.9 † | 8-nitro-1-phenyl-4-amino-3H-1,5-benzodiazepin-2-one | [37594](https://pubchem.ncbi.nlm.nih.gov/compound/37594) | 36975-99-2 |
| [[File:Compound-6i_structure.png | 120px]] | Compound 6i | 8.6 † | 9-chloro-11-phenyl-6,11-dihydro-5H-pyrimido[4,5-b][1,5]benzodiazepin-5-one | ||
| [[File:Oxazolam.svg | 120px]] | Oxazolam | 10-chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydrobenzo[f]oxazolo[3,2-d] [1,4]diazepin-6(5H)-one | [62779](https://pubchem.ncbi.nlm.nih.gov/compound/62779) | 24143-17-7 | |
| [[File:Cloxazolam.svg | 120px]] | Cloxazolam | 10-chloro-11b-(2-chlorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one | [2816](https://pubchem.ncbi.nlm.nih.gov/compound/2816) | 24166-13-0 | |
| [[File:Mexazolam.svg | 120px]] | Mexazolam | 10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one | [4177](https://pubchem.ncbi.nlm.nih.gov/compound/4177) | 31868-18-5 | |
| [[File:Flutazolam.svg | 120px]] | Flutazolam | 10-chloro-11b-(2-fluorophenyl)-7-(2-hydroxyethyl)-3,5-dihydro-2H-[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one | [3398](https://pubchem.ncbi.nlm.nih.gov/compound/3398) | 27060-91-9 | |
| [[File:Haloxazolam structure.svg | 120px]] | Haloxazolam | 10-bromo-11b-(2-fluorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one | [3563](https://pubchem.ncbi.nlm.nih.gov/compound/3563) | 59128-97-1 | |
| [[File:Ketazolam.svg | 120px]] | Ketazolam | 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d] [1,4]benzodiazepine-4,7(6H)-dione | [33746](https://pubchem.ncbi.nlm.nih.gov/compound/33746) | 27223-35-4 | |
| [[File:U-35005_structure.png | 120px]] | U-35005 | 8.3665 / 4.3nM | 6-(2-chlorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [21680194](https://pubchem.ncbi.nlm.nih.gov/compound/21680194) | |
| [[File:4'-Chlorodeschloroalprazolam_structure.png | 120px]] | [4'-Chlorodeschloroalprazolam](4-chlorodeschloroalprazolam) | 6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | [142641556](https://pubchem.ncbi.nlm.nih.gov/compound/142641556) | 92262-72-1 | |
| [[File:Estazolam.svg | 120px]] | Estazolam | 8.0706 / 8.5nM | 8-chloro-6-phenyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [3261](https://pubchem.ncbi.nlm.nih.gov/compound/3261) | 29975-16-4 |
| [[File:Alprazolam.svg | 120px]] | Alprazolam | 7.699 / 20nM | 8-chloro-6-phenyl-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [2118](https://pubchem.ncbi.nlm.nih.gov/compound/2118) | 28981-97-7 |
| [[File:Triazolam.svg | 120px]] | Triazolam | 8.3979 / 4nM | 8-chloro-6-(2-chlorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [5556](https://pubchem.ncbi.nlm.nih.gov/compound/5556) | 28911-01-5 |
| [[File:Alphahydroxytriazolam_structure.png | 120px]] | alpha-Hydroxytriazolam | 8.3768 / 4.2nM | 8-chloro-6-(2-chlorophenyl)-1-hydroxymethyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [1963](https://pubchem.ncbi.nlm.nih.gov/compound/1963) | 37115-45-0 |
| [[File:Flualprazolam_structure.svg | 120px]] | Flualprazolam | 8.3 † | 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [10359044](https://pubchem.ncbi.nlm.nih.gov/compound/10359044) | 28910-91-0 |
| [[File:Iso-flualprazolam_structure.png | 120px]] | Iso-flualprazolam | 8-fluoro-6-(2-chlorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | |||
| [[File:Desmethyltriazolam_structure.png | 120px]] | Desmethyltriazolam | 8.3 † | 8-chloro-6-(2-chlorophenyl)-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [826660](https://pubchem.ncbi.nlm.nih.gov/compound/826660) | 42292-42-2 |
| [[File:Nitrazolam.svg | 120px]] | Nitrazolam | 8.5 † | 8-nitro-6-phenyl-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [20317278](https://pubchem.ncbi.nlm.nih.gov/compound/20317278) | 28910-99-8 |
| [[File:Desmethylnitrazolam_structure.png | 120px]] | Desmethylnitrazolam | 8.8 † | 8-nitro-6-phenyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [20317280](https://pubchem.ncbi.nlm.nih.gov/compound/20317280) | 30858-58-3 |
| [[File:Clonazolam skeletal formula.svg | 120px]] | Clonazolam | 9.5 † | 8-nitro-6-(2-chlorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [12317881](https://pubchem.ncbi.nlm.nih.gov/compound/12317881) | 33887-02-4 |
| [[File:Flunitrazolam Structural Formula V.1.svg | 120px]] | Flunitrazolam | 8.8 † | 8-nitro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [137700379](https://pubchem.ncbi.nlm.nih.gov/compound/137700379) | 2243815-18-9 |
| [[File:Flubromazolam.svg | 120px]] | Flubromazolam (JYI-73) | 8.8 † | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [21930924](https://pubchem.ncbi.nlm.nih.gov/compound/21930924) | 612526-40-6 |
| [[File:BDBM50011621_structure.png | 120px]] | Fluiodomazolam (BDBM50011621) | 8-iodo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [14851835](https://pubchem.ncbi.nlm.nih.gov/compound/14851835) | ||
| [[File:SCHEMBL7327294_structure.png | 120px]] | Triflumazolam (SCHEMBL7327294) | 8-trifluoromethyl-6-phenyl-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [19010444](https://pubchem.ncbi.nlm.nih.gov/compound/19010444) | 28910-98-7 | |
| [[File:JYI-70_structure.png | 120px]] | JYI-70 | 8-ethynyl-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [14851900](https://pubchem.ncbi.nlm.nih.gov/compound/14851900) | ||
| [[File:XLI-296_structure.png | 120px]] | XLI-296 | 8-ethynyl-6-(2-chlorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [14851901](https://pubchem.ncbi.nlm.nih.gov/compound/14851901) | ||
| [[File:Clobromazolam_structure.png | 120px]] | Clobromazolam (DM-II-90) | 8.2 † | 8-bromo-6-(2-chlorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [1032830](https://pubchem.ncbi.nlm.nih.gov/compound/1032830) | 87213-50-1 |
| [[File:Bromazolam_structure.png | 120px]] | Bromazolam (XLI-268) | 8.5 † | 8-bromo-6-phenyl-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [12562546](https://pubchem.ncbi.nlm.nih.gov/compound/12562546) | 71368-80-4 |
| [[File:Ethylbromazolam.svg | 120px]] | Ethylbromazolam | 8-bromo-6-phenyl-1-ethyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | 105470-75-5 | ||
| [[File:Pyrazolam-skeletal.svg | 120px]] | Pyrazolam (SH-I-04) | 8.1 † | 8-bromo-6-(pyridin-2-yl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [12562545](https://pubchem.ncbi.nlm.nih.gov/compound/12562545) | 39243-02-2 |
| [[File:Pyclazolam_structure.png | 120px]] | Pyclazolam | 8.2 † | 8-chloro-6-(pyridin-2-yl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [20368150](https://pubchem.ncbi.nlm.nih.gov/compound/20368150) | |
| [[File:Pynazolam_structure.png | 120px]] | Pynazolam | 9.4 † | 8-nitro-6-(pyridin-2-yl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [20368157](https://pubchem.ncbi.nlm.nih.gov/compound/20368157) | 2034366-97-5 |
| [[File:Pyeazolam_structure.png | 120px]] | Pyeazolam (SH-TRI-108) | 7.9 † | 8-ethynyl-6-(pyridin-2-yl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [71811108](https://pubchem.ncbi.nlm.nih.gov/compound/71811108) | 1349115-59-8 |
| [[File:Adinazolam.svg | 120px]] | Adinazolam | 6.8697 / 135nM | 8-chloro-6-phenyl-1-(N,N-dimethylaminomethyl)-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [37632](https://pubchem.ncbi.nlm.nih.gov/compound/37632) | 37115-32-5 |
| [[File:U-42352_structure.png | 120px]] | U-42352 | 8-chloro-6-phenyl-1-(N-methylaminomethyl)-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [119094](https://pubchem.ncbi.nlm.nih.gov/compound/119094) | 37115-33-6 | |
| [[File:Fluadinazolam_structure.png | 120px]] | Fluadinazolam | 7.1 † | 8-chloro-6-(2-fluorophenyl)-1-(N,N-dimethylaminomethyl)-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [21537253](https://pubchem.ncbi.nlm.nih.gov/compound/21537253) | 37391-59-6 |
| [[File:U-43465F_structure.png | 120px]] | U-43465 F | 7.9431 | 8-chloro-1-[2-(dimethylamino) ethyl]-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | [134388](https://pubchem.ncbi.nlm.nih.gov/compound/134388) | 83983-74-8 |
| [[File:Ro11-5073_structure.png | 120px]] | Ro11-5073 | 8.4815 / 3.3nM | (4S)-8-chloro-6-(2-fluorophenyl)-1,4-dimethyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [101637147](https://pubchem.ncbi.nlm.nih.gov/compound/101637147) | |
| [[File:Ro11-6679_structure.png | 120px]] | Ro11-6679 | 8.3979 / 4nM | 8-nitro-6-(2-fluorophenyl)-1,4-dimethyl-4H-benzo[f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | ||
| [[File:Ro17-4582_structure.png | 120px]] | Ro17-4582 | 8.4559 / 3.5nM | 4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | ||
| [[File:Etizolam.svg | 120px]] | Etizolam | 8.5086 / 3.1nM | 2-ethyl-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [3307](https://pubchem.ncbi.nlm.nih.gov/compound/3307) | 40054-69-1 |
| [[File:Deschloroetizolam.svg | 120px]] | Deschloroetizolam | 8.5 † | 2-ethyl-4-phenyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [827322](https://pubchem.ncbi.nlm.nih.gov/compound/827322) | 40054-73-7 |
| [[File:Desmethyletizolam.svg | 120px]] | Desmethyletizolam | 2-ethyl-4-(2-chlorophenyl)-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [12434325](https://pubchem.ncbi.nlm.nih.gov/compound/12434325) | 40054-68-0 | |
| [[File:Fluetizolam_structure.png | 120px]] | Fluetizolam | 8.8 † | 2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [12434320](https://pubchem.ncbi.nlm.nih.gov/compound/12434320) | 40054-88-4 |
| [[File:Nitizolam_structure.png | 120px]] | Nitizolam | 2-nitro-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [70600959](https://pubchem.ncbi.nlm.nih.gov/compound/70600959) | ||
| [[File:Iprizolam_structure.png | 120px]] | Iprotizolam | 2-isopropyl-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [67727941](https://pubchem.ncbi.nlm.nih.gov/compound/67727941) | ||
| [[File:Ro11-1465_structure.png | 120px]] | Clotizolam (Ro11-1465) | 8.8539 / 1.4nM | 2-chloro-4-(2-chlorophenyl)-9-methyl-4H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [3041455](https://pubchem.ncbi.nlm.nih.gov/compound/3041455) | 54123-06-7 |
| [[File:Deschloroclotizolam_structure.png | 120px]] | Deschloroclotizolam | 2-chloro-4-phenyl-9-methyl-4H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [157010678](https://pubchem.ncbi.nlm.nih.gov/compound/157010678) | 1629324-97-5 | |
| [[File:Fluclotizolam_structure.png | 120px]] | Fluclotizolam | 9.1 † | 2-chloro-4-(2-fluorophenyl)-9-methyl-4H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [21317700](https://pubchem.ncbi.nlm.nih.gov/compound/21317700) | 54123-15-8 |
| [[File:Difluclotizolam_structure.png | 120px]] | Difluclotizolam | 2-chloro-4-(2,6-difluorophenyl)-9-methyl-4H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [21317683](https://pubchem.ncbi.nlm.nih.gov/compound/21317683) | ||
| [[File:Brotizolam.svg | 120px]] | Brotizolam | 8.9208 | 2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [2451](https://pubchem.ncbi.nlm.nih.gov/compound/2451) | 57801-81-7 |
| [[File:Flubrotizolam_structure.png | 120px]] | Flubrotizolam (LS-152,574) | 9.6 † | 2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [3044878](https://pubchem.ncbi.nlm.nih.gov/compound/3044878) | 57801-95-3 |
| [[File:Ro14-1636_structure.png | 120px]] | Ro14-1636 | 8.8239 | 2-iodo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [14851924](https://pubchem.ncbi.nlm.nih.gov/compound/14851924) | |
| [[File:Ciclotizolam structure.svg | 120px]] | Ciclotizolam | 8.0 † | 2-bromo-4-(2-chlorophenyl)-9-cyclohexyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [71949](https://pubchem.ncbi.nlm.nih.gov/compound/71949) | 58765-21-2 |
| Ro11-7800 | 8.5376 / 2.9nM | (2-chloro-4-(2-chlorophenyl)-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a] [1,4]diazepin-9-yl)methanamine | ||||
| [[File:Zapizolam.svg | 120px]] | Zapizolam | 8.8 † | 8-chloro-6-(2-chlorophenyl)-4H-pyrido[2,3-f] [1,2,4]triazolo[4,3-a] [1,4]diazepine | [68832](https://pubchem.ncbi.nlm.nih.gov/compound/68832) | 64098-32-4 |
| [[File:Rilmazafone metabolite.svg | 120px]] | Rilmazolam (LS-188,599) | 7.3 † | 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo[1,5-a] [1,4]benzodiazepine-2-carboxamide | [148494](https://pubchem.ncbi.nlm.nih.gov/compound/148494) | 50330-59-1 |
| [[File:Midazolam.svg | 120px]] | Midazolam | 8.3188 / 4.8nM | 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a] [1,4]benzodiazepine | [4192](https://pubchem.ncbi.nlm.nih.gov/compound/4192) | 59467-70-8 |
| [[File:Alphahydroxymidazolam_structure.png | 120px]] | alpha-Hydroxymidazolam | 8.3468 / 4.5nM | 8-chloro-6-(2-fluorophenyl)-1-hydroxymethyl-4H-imidazo[1,5-a] [1,4]benzodiazepine | [107917](https://pubchem.ncbi.nlm.nih.gov/compound/107917) | 59468-90-5 |
| [[File:Ro22-0284_structure.png | 120px]] | Ro22-0284 | 8-chloro-6-(2-fluorophenyl)-1-hydroxymethyl-4-hydroxy-4H-imidazo[1,5-a] [1,4]benzodiazepine | [10316307](https://pubchem.ncbi.nlm.nih.gov/compound/10316307) | 64740-68-7 | |
| [[File:Climazolam.svg | 120px]] | Climazolam | 8.1 † | 8-chloro-6-(2-chlorophenyl)-1-methyl-4H-imidazo[1,5-a] [1,4]benzodiazepine | [68790](https://pubchem.ncbi.nlm.nih.gov/compound/68790) | 59467-77-5 |
| [[File:Remimazolam.svg | 120px]] | Remimazolam | 8.3 † | methyl 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a] [1,4]benzodiazepin-4-yl]propanoate | [9824461](https://pubchem.ncbi.nlm.nih.gov/compound/9824461) | 308242-62-8 |
| [[File:Ro15-8670_structure.png | 120px]] | Ro15-8670 | 7.8239 / 15nM | ethyl 8-chloro-6-phenyl-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [14907889](https://pubchem.ncbi.nlm.nih.gov/compound/14907889) | |
| [[File:JYI-32_structure.png | 120px]] | JYI-32 | ethyl 8-bromo-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [21930922](https://pubchem.ncbi.nlm.nih.gov/compound/21930922) | ||
| [[File:JY-XHE-057_structure.png | 120px]] | JY-XHE-057 | ethyl 8-ethynyl-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [21065283](https://pubchem.ncbi.nlm.nih.gov/compound/21065283) | ||
| [[File:Ro16-0529_structure.png | 120px]] | Ro16-0529 | 7.8539 / 14nM | tert-butyl 7-chloro-6-phenyl-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | ||
| [[File:Ro21-5205_structure.png | 120px]] | Ro21-5205 | 8.1308 / 7.4nM | methyl 8-chloro-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [12801973](https://pubchem.ncbi.nlm.nih.gov/compound/12801973) | |
| [[File:SH-053-R-CH3-2′F.svg | 120px]] | SH-053-R-CH3-2'F | 7.9 † | ethyl (4R)-8-ethynyl-6-(2-fluorophenyl)-4-methyl-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [11574585](https://pubchem.ncbi.nlm.nih.gov/compound/11574585) | 872874-14-1 |
| [[File:HZ-166_structure.png | 120px]] | HZ-166 | ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10309028](https://pubchem.ncbi.nlm.nih.gov/compound/10309028) | 612527-56-7 | |
| [[File:MP-III-022_structure.png | 120px]] | MP-III-022 | 9.1 † | (4R)-8-ethynyl-6-(2-fluorophenyl)-N,4-dimethyl-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | [130439777](https://pubchem.ncbi.nlm.nih.gov/compound/130439777) | |
| [[File:GL-II-73_structure.png | 120px]] | GL-II-73 | (4R)-8-ethynyl-6-(2-fluorophenyl)-N,N,4-trimethyl-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | [130439778](https://pubchem.ncbi.nlm.nih.gov/compound/130439778) | ||
| [[File:YT-III-31_structure.png | 120px]] | YT-III-31 | 8-ethynyl-6-phenyl-N-methyl-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | [49848318](https://pubchem.ncbi.nlm.nih.gov/compound/49848318) | ||
| Ro22-1892 | 7.9208 / 12nM | 8-chloro-6-(2-fluorophenyl)-3-(isopropoxycarbonyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine 5-oxide | ||||
| [[File:Ro22-0992_structure.png | 120px]] | Ro22-0992 | 7.8861 / 13nM | 8-chloro-6-(2-chlorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylic acid | ||
| [[File:Ro21-8137_structure.png | 120px]] | Ro21-8137 | 8.4559 / 3.5nM | 8-chloro-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | ||
| [[File:Ro21-8384_structure.png | 120px]] | Ro21-8384 | 8.4202 | 8-chloro-6-(2-chlorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | [162997](https://pubchem.ncbi.nlm.nih.gov/compound/162997) | 63176-94-3 |
| [[File:Imidazenil.svg | 120px]] | Imidazenil | 8.8 † | 8-fluoro-6-(2-bromophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | [119194](https://pubchem.ncbi.nlm.nih.gov/compound/119194) | 151271-08-8 |
| [[File:Ro23-0364_structure.png | 120px]] | Ro23-0364 | 6-(2-chlorophenyl)-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | [194998](https://pubchem.ncbi.nlm.nih.gov/compound/194998) | 113066-25-4 | |
| [[File:Ro21-8482_structure.png | 120px]] | Ro21-8482 | 7.585 / 26nM | 8-chloro-6-(2-chlorophenyl)-1-[(dimethylamino)methyl]-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | ||
| [[File:Loprazolam.svg | 120px]] | Loprazolam | 8.2007 | (2Z)-6-(2-chlorophenyl)-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-2,4-dihydro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-one | [3033860](https://pubchem.ncbi.nlm.nih.gov/compound/3033860) | 61197-73-7 |
| [[File:Fluloprazolam.svg | 120px]] | Fluloprazolam | 8.0 † | (2Z)-6-(2-fluorophenyl)-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-2,4-dihydro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-one | [12371485](https://pubchem.ncbi.nlm.nih.gov/compound/12371485) | |
| [[File:PS-I-35.svg | 120px]] | PS-I-35 | (2Z)-6-phenyl-2-[(4-methyl-1-piperazinyl)methylene]-8-bromo-2,4-dihydro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-one | [72660859](https://pubchem.ncbi.nlm.nih.gov/compound/72660859) | ||
| Ro14-1359 | 7.1549 / 70nM | 7-chloro-5-(2-fluorophenyl)-1H-benzo[b]azepin-2(3H)-one | ||||
| Ro15-8867 | 7.6021 / 25nM | 7-nitro-5-(2-chlorophenyl)-1H-benzo[b]azepin-2(3H)-one | ||||
| [[File:Ro14-7187_structure.png | 120px]] | Ro14-7187 | 6.3872 / 410nM | 1-methyl-6-phenyl-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepine | [85687871](https://pubchem.ncbi.nlm.nih.gov/compound/85687871) | |
| Ro13-9868 | 7.3768 / 42nM | 8-chloro-1-methyl-6-phenyl-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepine | ||||
| [[File:Ro14-5921_structure.png | 120px]] | Ro14-5921 | 7.7212 / 19nM | 8-chloro-6-(2-fluorophenyl)-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepine | [20449965](https://pubchem.ncbi.nlm.nih.gov/compound/20449965) | |
| [[File:Ro14-0304_structure.png | 120px]] | Ro14-0304 | 8.1871 / 6.5nM | 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepine | [20449964](https://pubchem.ncbi.nlm.nih.gov/compound/20449964) | |
| Ro14-2652 | 8.2518 / 5.6nM | (8-chloro-6-(2-fluorophenyl)-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepin-1-yl)methanamine | ||||
| [[File:Ro15-9270_structure.png | 120px]] | Ro15-9270 | 8.301 / 5nM | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepine | [20450010](https://pubchem.ncbi.nlm.nih.gov/compound/20450010) | |
| Ro14-0609 | 7.6126 / 24.4nM | 8-chloro-6-(2-fluorophenyl)-5,6-dihydro-4H-benzo[f] [1,2,4]triazolo[4,3-a]azepine | ||||
| Ro15-2201 | 8.8239 / 1.5nM | methyl 6-phenyl-4H-benzo[f]imidazo[1,5-a]azepine-3-carboxylate | ||||
| Ro15-0791 | 8.6021 / 2.5nM | ethyl 6-phenyl-4H-benzo[f]imidazo[1,5-a]azepine-3-carboxylate | ||||
| Ro15-2200 | 8.3768 / 4.2nM | ethyl 6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a]azepine-3-carboxylate | ||||
| Ro14-3929 | 7.7959 / 16nM | ethyl 8-chloro-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a]azepine-3-carboxylate | ||||
| Ro14-3930 | 7.8239 / 15nM | 8-chloro-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a]azepine-3-carboxamide | ||||
| Ro14-5568 | 6.6383 / 230nM | 8-chloro-6-(2-fluorophenyl)-4H-benzo[f]imidazo[1,5-a]azepine | ||||
| [[File:Ro22-1274_structure.png | 120px]] | Ro22-1274 | 7.1249 / 75nM | 8-chloro-1-(2-fluorophenyl)-3H-benzo[c]azepine | [13271760](https://pubchem.ncbi.nlm.nih.gov/compound/13271760) | 89376-31-8 |
| Ro22-1251 | 7.9586 / 11nM | 9-chloro-2-methyl-7-phenyl-5H-benzo[c]pyrimido[4,5-e]azepine | ||||
| Ro22-1366 | 8.3979 / 4nM | 9-chloro-7-(2-fluorophenyl)-2-methyl-5H-benzo[c]pyrimido[4,5-e]azepine | ||||
| Ro22-2038 | 8.5528 / 2.8nM | 9-chloro-7-(2-fluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-amine | ||||
| Ro22-3245 | 8.5528 / 2.8nM | 9-chloro-7-(2-chlorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepine | ||||
| Ro22-3148 | 6.3768 / 420nM | 6-phenyl-2,4-dihydrobenzo[c] [1,2,3]triazolo[4,5-e]azepine | ||||
| Ro22-3147 | 8.284 / 5.2nM | 6-(2-chlorophenyl)-2,4-dihydrobenzo[c] [1,2,3]triazolo[4,5-e]azepine | ||||
| Ro22-0780 | 7.9586 / 11nM | 8-chloro-6-phenyl-2,4-dihydrobenzo[c] [1,2,3]triazolo[4,5-e]azepine | ||||
| Ro22-2466 | 8.7212 / 1.9nM | 8-chloro-6-(2-fluorophenyl)-2,4-dihydrobenzo[c] [1,2,3]triazolo[4,5-e]azepine | ||||
| Ro22-2468 | 8.6021 | |||||
| [[File:Ro22-8515_structure.png | 120px]] | Ro22-8515 | 8-chloro-6-(2-chlorophenyl)-1,4-dihydropyrrolo[3,4-d] [2]benzazepin-3(2H)-one | [145981](https://pubchem.ncbi.nlm.nih.gov/compound/145981) | ||
| [[File:Ro14-5974_structure.png | 120px]] | Ro14-5974 | 8.1938 / 6.4nM | (S)-ethyl 9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | [10041121](https://pubchem.ncbi.nlm.nih.gov/compounds/10041121) | 88552-32-3 |
| [[File:Ro15-4941_structure.png | 120px]] | Ro15-4941 | 8.7696 / 1.7nM | (S)-ethyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||
| [[File:Ro14-5975_structure.png | 120px]] | Ro14-5975 | 7.2076 / 62nM | (S)-ethyl 7-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||
| [[File:Ro16-3607_structure.png | 120px]] | Ro16-3607 | 7.3372 / 46nM | (S)-tert-butyl 8-methoxy-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||
| [[File:Ro16-6624_structure.png | 120px]] | Ro16-6624 | 8 / 10nM | (S)-tert-butyl 8-ethyl-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||
| [[File:Ro16-3774_structure.png | 120px]] | Ro16-3774 | 8.4949 / 3.2nM | (S)-tert-butyl 8-methyl-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||
| Ro16-0071 | 8.4949 / 3.2nM | (S)-tert-butyl 9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-5824 | 8.4685 / 3.4nM | (S)-tert-butyl 8-(methylthio)-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-8912 | 8.2076 / 6.2nM | (S)-tert-butyl 8-fluoro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-4261 | 8.1135 / 7.7nM | (S)-tert-butyl 7-fluoro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-0075 | 8.6021 | |||||
| Ro16-6127 | 8.5086 / 3.1nM | (S)-tert-butyl 8-chloro-7-fluoro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-3058 | 7.0458 | |||||
| [[File:Bretazenil.svg | 120px]] | Bretazenil | 8.6576 | (S)-tert-butyl 8-bromo-9-oxo-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c] [1,4]benzodiazepine-1-carboxylate | [107926](https://pubchem.ncbi.nlm.nih.gov/compound/107926) | 84379-13-5 |
| [[File:EVT-201.svg | 120px]] | EVT-201 | 7-chloro-3-(5-[(dimethylamino)methyl]-1,2,4-oxadiazol-3-yl)-5-methyl-4,5-dihydro-6H-imidazo[1,5-a] [1,4]benzodiazepin-6-one | [9885841](https://pubchem.ncbi.nlm.nih.gov/compound/9885841) | 308239-86-3 | |
| [[File:FG-8205.svg | 120px]] | FG-8205 | 7-chloro-5-methyl-3-(5-propan-2-yl-1,2,4-oxadiazol-3-yl)-4H-imidazo[1,5-a] [1,4]benzodiazepin-6-one | [129710](https://pubchem.ncbi.nlm.nih.gov/compound/129710) | 122384-14-9 | |
| [[File:L-655,708.svg | 120px]] | L-655,708 | ethyl (13aS)-7-methoxy-9-oxo-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c] [1,4]benzodiazepine-1-carboxylate | [5311203](https://pubchem.ncbi.nlm.nih.gov/compound/5311203) | 130477-52-0 | |
| [[File:PWZ-029.svg | 120px]] | PWZ-029 | 8-chloro-3-(methoxymethyl)-5-methyl-4H-imidazo[1,5-a] [1,4]benzodiazepin-6-one | [9971547](https://pubchem.ncbi.nlm.nih.gov/compound/9971547) | ||
| [[File:Ro48-6791.svg | 120px]] | Ro48-6791 | 8-fluoro-5-methyl-3-(5-[(dipropylamino)methyl]-1,2,4-oxadiazol-3-yl)-4H-imidazo[1,5-a] [1,4]benzodiazepin-6-one | [9953485](https://pubchem.ncbi.nlm.nih.gov/compound/9953485) | 172407-17-9 | |
| [[File:Ro48-8684.svg | 120px]] | Ro48-8684 | 8-fluoro-5-methyl-3-(5-[(dipropylamino)methyl]-1,3-oxazol-2-yl)-4H-imidazo[1,5-a] [1,4]benzodiazepin-6-one | [9866317](https://pubchem.ncbi.nlm.nih.gov/compound/9866317) | ||
| [[File:Ro4882224_structure.png | 120px]] | Ro4882224 | 3,10-dichloro-9H-benzo[f]imidazo[1,5-a] [1,2,4]triazolo[1,5-d] [1,4]diazepine | [11673720](https://pubchem.ncbi.nlm.nih.gov/compound/11673720) | ||
| [[File:Ro4938581.svg | 120px]] | Ro4938581 | 3-bromo-10-(difluoromethyl)-9H-benzo[f]imidazo[1,5-a] [1,2,4]triazolo[1,5-d] [1,4]diazepine | [11624499](https://pubchem.ncbi.nlm.nih.gov/compound/11624499) | 883093-10-5 | |
| Ro16-6605 | 8.6778 | |||||
| Ro16-6048 | 8.4815 / 3.3nM | (S)-tert-butyl 9-oxo-8-(trifluoromethyl)-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-6950 | 8.5528 / 2.8nM | (S)-tert-butyl 8-nitro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-4019 | 8.8539 / 1.4nM | (S)-propyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-3031 | 8.6021 / 2.5nM | (S)-isopropyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-9906 | 8.7696 / 1.7nM | (S)-allyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-7081 | 8.585 | |||||
| Ro16-7082 | 8.2007 / 6.3nM | (S)-isobutyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-7083 | 8.5376 / 2.9nM | (13aS)-sec-butyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-9918 | 8.6383 / 2.3nM | (S)-cyclopropylmethyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro16-4020 | 8.585 | |||||
| Ro16-6654 | 8.3979 / 4nM | (S)-cyclohexyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro17-3206 | 8.4685 | |||||
| Ro17-3207 | 8.284 | |||||
| Ro16-4021 | 8.8239 | |||||
| Ro17-1302 | 8.2757 / 5.3nM | (S)-phenyl 8-chloro-9-oxo-11,12,13,13a-tetrahydro-9H-benzo[e]imidazo[5,1-c]pyrrolo[1,2-a] [1,4]diazepine-1-carboxylate | ||||
| Ro15-2427 | IC50 1000nM | 5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxamide | ||||
| [[File:Ro14-7437_structure.png | 120px]] | Ro14-7437 | 8.5229 / 3nM | ethyl 5-methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate | [127597](https://pubchem.ncbi.nlm.nih.gov/compounds/127597) | 83210-63-3 |
| [[File:Sarmazenil.svg | 120px]] | Sarmazenil (Ro15-3505) | 8.5686 / 2.7nM | ethyl 7-chloro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [71231](https://pubchem.ncbi.nlm.nih.gov/compound/71231) | 78771-13-8 |
| [[File:Ro15-1310_structure.png | 120px]] | Ro15-1310 | 8.1675 / 6.8nM | ethyl 8-chloro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [114888](https://pubchem.ncbi.nlm.nih.gov/compounds/114888) | 78756-33-9 |
| [[File:Ro15-1746_structure.png | 120px]] | Ro15-1746 | IC50 1000nM | ethyl 9-chloro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | ||
| [[File:Ro15-3237_structure.png | 120px]] | Ro15-3237 | IC50 1000nM | ethyl 10-chloro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | ||
| Ro15-5623 | 8.699 | |||||
| [[File:Flumazenil.svg | 120px]] | Flumazenil | 8.6021 | ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [3373](https://pubchem.ncbi.nlm.nih.gov/compound/3373) | 78755-81-4 |
| [[File:Ro15-4513.svg | 120px]] | Ro15-4513 | ethyl 8-azido-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [5081](https://pubchem.ncbi.nlm.nih.gov/compound/5081) | 91917-65-6 | |
| [[File:RY-031_structure.png | 120px]] | RY-031 | ethyl 8-ethyl-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10245056](https://pubchem.ncbi.nlm.nih.gov/compound/10245056) | ||
| [[File:TG-4-29_structure.png | 120px]] | TG-4-29 | ethyl 8-vinyl-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10591116](https://pubchem.ncbi.nlm.nih.gov/compound/10591116) | ||
| [[File:RY-080_structure.png | 120px]] | RY-080 | ethyl 8-ethynyl-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [5311418](https://pubchem.ncbi.nlm.nih.gov/compound/5311418) | ||
| [[File:YT-II-76_structure.png | 120px]] | YT-II-76 | ethyl 8-cyclopropyl-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [46214569](https://pubchem.ncbi.nlm.nih.gov/compound/46214569) | ||
| [[File:SVO-8-14_structure.png | 120px]] | SVO-8-14 | ethyl 8-allyl-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [15316982](https://pubchem.ncbi.nlm.nih.gov/compound/15316982) | ||
| [[File:SVO-8-30_structure.png | 120px]] | SVO-8-30 | ethyl 8-(furan-2-yl)-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [15316986](https://pubchem.ncbi.nlm.nih.gov/compound/15316986) | ||
| [[File:SVO-8-67_structure.png | 120px]] | SVO-8-67 | ethyl 8-phenyl-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [15316984](https://pubchem.ncbi.nlm.nih.gov/compound/15316984) | ||
| [[File:TG-4-39_structure.png | 120px]] | TG-4-39 | ethyl 8-(thiophen-2-yl)-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [15316985](https://pubchem.ncbi.nlm.nih.gov/compound/15316985) | ||
| [[File:CD-214_structure.png | 120px]] | CD-214 | cyclopropyl 8-chloro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [101652266](https://pubchem.ncbi.nlm.nih.gov/compound/101652266) | ||
| [[File:DM-139_structure.png | 120px]] | DM-139 | t-butyl 8-(pyrrolidin-1-yl)-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10547937](https://pubchem.ncbi.nlm.nih.gov/compound/10547937) | ||
| [[File:DM-146_structure.png | 120px]] | DM-146 | t-butyl 8-(piperidin-1-yl)-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10834569](https://pubchem.ncbi.nlm.nih.gov/compound/10834569) | ||
| [[File:DM-173_structure.png | 120px]] | DM-173 | t-butyl 8-(dimethylamino)-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10808192](https://pubchem.ncbi.nlm.nih.gov/compound/10808192) | ||
| [[File:DM-215_structure.png | 120px]] | DM-215 | t-butyl 8-methoxy-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10807310](https://pubchem.ncbi.nlm.nih.gov/compound/10807310) | ||
| [[File:Ro19-4603_structure.png | 120px]] | Ro19-4603 | t-butyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate | [127382](https://pubchem.ncbi.nlm.nih.gov/compound/127382) | 99632-94-7 | |
| [[File:Iomazenil.svg | 120px]] | Iomazenil | ethyl 7-iodo-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a] [1,4]diazepine-3-carboxylate | [10251042](https://pubchem.ncbi.nlm.nih.gov/compound/10251042) | 127985-21-1 | |
| Ro17-9741 | 8.6198 / 2.4nM | (S)-methyl 8-chloro-9-oxo-9,11,12,12a-tetrahydroazeto[1,2-a]benzo[e]imidazo[5,1-c] [1,4]diazepine-1-carboxylate | ||||
| Ro16-0858 | 8.8861 | ethyl 8-chloro-9-oxo-12,12a-dihydro-9H,11H-azeto[1,2-a]benzo[e]imidazo[5,1-c] [1,4]diazepine-1-carboxylate | ||||
| Ro16-0153 | 8.2757 | tert-butyl 8-chloro-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1-c]benzo[e]imidazo[1,5-a] [1,4]diazepine-1-carboxylate | ||||
| [[File:Ro17-1812_structure.png | 120px]] | Ro17-1812 | 8.8861 | (S)-cyclopropylmethyl 8-chloro-9-oxo-9,11,12,12a-tetrahydroazeto[1,2-a]benzo[e]imidazo[5,1-c] [1,4]diazepine-1-carboxylate | [146197](https://pubchem.ncbi.nlm.nih.gov/compound/146197) | 90450-01-4 |
| Ro17-3211 | 8.62 | |||||
| Ro17-3401 | 9.0458 | |||||
| Ro17-3620 | 8.2924 | |||||
| Ro16-9351 | 8.4318 | |||||
| Ro16-9905 | 8.9208 | |||||
| Ro17-1338 | 9 | |||||
| [[File:Zopiclone.svg | 120px]] | Zopiclone | 7.5086 | 6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate | [5735](https://pubchem.ncbi.nlm.nih.gov/compound/5735) | 43200-80-2 |
| [[File:Suriclone.svg | 120px]] | Suriclone | 8.6778 | [6-(7-chloro- 1,8-naphthyridin-2-yl)- 5-oxo- 3,7-dihydro- 2H-[1,4]dithiino[2,3-c]pyrrol- 7-yl]4-methylpiperazine- 1-carboxylate | [40903](https://pubchem.ncbi.nlm.nih.gov/compound/40903) | 53813-83-5 |
| [[File:CL-218,872.svg | 120px]] | CL-218,872 | 6.9208 | 3-methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[3,4-f]pyridazine | [107950](https://pubchem.ncbi.nlm.nih.gov/compound/107950) | 66548-69-4 |
| [[File:GBLD-345_structure.png | 120px]] | GBLD-345 | 9 | 2-(4-aminophenyl)-3-methoxy-N-[(3-methoxyphenyl)methyl]imidazo[2,1-f]pyridazin-6-amine | [4602899](https://pubchem.ncbi.nlm.nih.gov/compound/4602899) | 122479-08-7 |
|}
References
References
- (August 1984). "The psychopharmacological effects of premazepam, diazepam and placebo in healthy human subjects". British Journal of Clinical Pharmacology.
- (January 2003). "Biomarkers for the effects of benzodiazepines in healthy volunteers". British Journal of Clinical Pharmacology.
- "Benzodiazepine Names". non-benzodiazepines.org.uk.
- (March 2007). "Benzodiazepine Equivalence Table". benzo.org.uk.
- (July 1995). "Benzodiazepine Equivalence Charts". dr-bob.org.
- (November 2015). "American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults". Journal of the American Geriatrics Society.
- (15 May 2004). "Clinical geriatric psychopharmacology". Lippincott Williams & Wilkins.
- (2005). "Dose adjustment in patients with liver disease". Drug Safety.
- (August 2008). "Benzodiazepines in epilepsy: pharmacology and pharmacokinetics". Acta Neurologica Scandinavica.
- (July 1994). "Guidelines for the rational use of benzodiazepines. When and what to use". Drugs.
- "benzo.org.uk: Benzodiazepines: How They Work & How to Withdraw, Prof C H Ashton DM, FRCP, 2002".
- "Benzodiazepine Equivalence Chart".
- (April 2007). "Benzodiazepine Equivalence Table".
- (31 July 2018). "Benzodiazepine Equivalency Table".
- "Benzodiazepines Information for GPs". Drug and Alcohol Services South Australia.
- (March 2012). "The role of alprazolam for the treatment of panic disorder in Australia". The Australian and New Zealand Journal of Psychiatry.
- Ashton Manual
- (June 1996). "Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol". British Journal of Clinical Pharmacology.
- (22 August 2022). "Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects". Neurology International.
- "NMS Labs Report". NMS Labs.
- (2014). "Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics". Drug Testing and Analysis.
- Health Santé Canada, Federal Government of Canada. (January 20, 2012). "Status Decision of Controlled and Non-Controlled Substances". Controlled Drugs and Substances Act.
- Indiana General Assembly. "House Bill 1019 - Controlled substances".
- "Benzodiazepine Names". non-benzodiazepines.org.uk.
- (November 2013). "Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics". Journal of Mass Spectrometry.
- (January 2018). "Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine". Drug Testing and Analysis.
- (September 2015). "Comparison of haloperidol and midazolam in restless management of patients referred to the Emergency Department: A double-blinded, randomized clinical trial". Journal of Research in Medical Sciences.
- (1989). "Pharmacokinetics of flutoprazepam, a novel benzodiazepine drug, in normal subjects". European Journal of Drug Metabolism and Pharmacokinetics.
- (August 1985). "Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly". British Journal of Clinical Pharmacology.
- (2011). "Benzodiazepines: A Guide to Safe Prescribing". The Carlat Report: Psychiatry.
- Vancouver Hospital Pharmaceutical Sciences. "Comparison of Benzodiazepines".
- "Characterization of the designer benzodiazepines pyrazolam and flubromazepam and study on their detectability in human serum and urine samples".
- "Romazicon 2 (flumazenil) 3 Injection". Genentech, Inc..
- ["Flumazenil Injection, Solution App Pharmaceuticals, Llc]". U.S. National Library of Medicine.
- (2002). "Synopsis of pediatric emergency medicine.". Lippincott Williams & Wilkins..
- "Toxicological analyses".
- (2004). "Position paper: gastric lavage". Journal of Toxicology. Clinical Toxicology.
- "APPG for Involuntary Tranquilliser Addiction". benzo.org.uk.
- (January 1979). "The benzodiazepine story". Journal of Medicinal Chemistry.
- (1994). "Quantitative structure-activity relationships of the benzodiazepines. a review and reevaluation". Chemical Reviews.
- Edinoff AN, Nix CA, Odisho AS, Babin CP, Derouen AG, Lutfallah SC, Cornett EM, Murnane KS, Kaye AM, Kaye AD. (Aug 2022). "Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects". Neurol Int.
- Yu X, Greenblatt HK, Greenblatt DJ. (Feb 2023). "Designer benzodiazepines: an update". Expert Rev Clin Pharmacol.
- (1985). "Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists". Adv. Drug Res.
- (January 1998). "Atomistic Topological Indices Applied to Benzodiazepines using Various Regression Methods". Quantitative Structure-Activity Relationships.
- (November 2003). "Topological modeling of benzodiazepine receptor binding". Bioorganic & Medicinal Chemistry.
- (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry.
- (1983). "Handbook of Psychopharmacology". Springer.
- (1996). "Studies in Medicinal Chemistry". CRC Press.
- (March 2014). "Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects". Brain Research.
- (June 2018). "New benzodiazepines for sedation". Best Practice & Research. Clinical Anaesthesiology.
- (2015). "A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model". International Journal of Medicinal Chemistry.
- (June 2015). "Designer benzodiazepines: A new challenge". World Psychiatry.
- (2018). "New Psychoactive Substances".
- (January 2018). "The emergence of new psychoactive substance (NPS) benzodiazepines: A review". Drug Testing and Analysis.
- (May 2018). "The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines". Science & Justice.
- (July 2019). "An expanding world of new psychoactive substances-designer benzodiazepines". Neurotoxicology.
- (September 1977). "Electronic factors in the structure-activity relationship of some 1,4-benzodiazepin-2-ones". Journal of Medicinal Chemistry.
- (February 1980). "Rm values and structure-activity relationship of benzodiazepines". Journal of Medicinal Chemistry.
- Catalani V, Floresta G, Botha M, Corkery JM, Guirguis A, Vento A, Abbate V, Schifano F. (Jan 2023). "In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines". Chem Biol Drug Des.
- (September 2010). "1,4-Benzodiazepin-2-ones in medicinal chemistry". Future Medicinal Chemistry.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about List of benzodiazepines — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report